Literature DB >> 23504331

Improved post-transplant survival in the United States for patients with cholangiocarcinoma after 2000.

Reena J Salgia1, Amit G Singal, Sherry Fu, Shawn Pelletier, Jorge A Marrero.   

Abstract

BACKGROUND: The incidence of cholangiocarcinoma (CCA) continues to rise. Orthotopic liver transplantation (OLT) can be used for selected patients with localized but unresectable hilar CCA. Although initial post-OLT survival rates were poor, outcomes after introduction of the Mayo Clinic protocol have been more promising and there has been increased interest in OLT for CCA nationally. AIMS: The aim of this study is to determine post-transplant survival and prognostic factors for patients undergoing OLT for CCA.
METHODS: A retrospective analysis of all patients with CCA listed nationwide for OLT between October 1987 and May 2008 was performed using the Scientific Registry of Transplant Recipients database. Survival curves were generated using the Kaplan-Meier method and compared using log-rank test.
RESULTS: Of 595 patients with CCA listed for OLT, 359 (60.3 %) underwent OLT. Median age at OLT was 49 years, 66 % were male and 91 % were Caucasian. The median follow-up time was 2 years. There has been an increasing number of liver transplants performed for CCA since 2000. The 1- and 5-year probability of survival was 85.8 and 51.4 %, respectively. On multivariate analysis, significant prognostic factors for decreased post-OLT survival included transplant before 2000 (HR 11.25, 95 % CI 1.28-98.7) and acute cellular rejection (HR 5.64, 95 % CI 1.14-27.8).
CONCLUSIONS: Survival after transplant for CCA has improved over time, and OLT is being used more frequently in the treatment of CCA. Significant predictors of post-OLT survival include a history of acute rejection and date of transplant in relation to the publication of Mayo protocol results.

Entities:  

Mesh:

Year:  2013        PMID: 23504331     DOI: 10.1007/s10620-013-2626-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  20 in total

1.  Liver transplantation for cholangiocarcinoma: results in 207 patients.

Authors:  C G Meyer; I Penn; L James
Journal:  Transplantation       Date:  2000-04-27       Impact factor: 4.939

Review 2.  Review article: the modern diagnosis and therapy of cholangiocarcinoma.

Authors:  H Malhi; G J Gores
Journal:  Aliment Pharmacol Ther       Date:  2006-05-01       Impact factor: 8.171

3.  Management strategies in resection for hilar cholangiocarcinoma.

Authors:  H Bismuth; R Nakache; T Diamond
Journal:  Ann Surg       Date:  1992-01       Impact factor: 12.969

4.  Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers.

Authors:  Sarwa Darwish Murad; W Ray Kim; Denise M Harnois; David D Douglas; James Burton; Laura M Kulik; Jean F Botha; Joshua D Mezrich; William C Chapman; Jason J Schwartz; Johnny C Hong; Jean C Emond; Hoonbae Jeon; Charles B Rosen; Gregory J Gores; Julie K Heimbach
Journal:  Gastroenterology       Date:  2012-04-12       Impact factor: 22.682

5.  Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases.

Authors:  J R Madariaga; S Iwatsuki; S Todo; R G Lee; W Irish; T E Starzl
Journal:  Ann Surg       Date:  1998-01       Impact factor: 12.969

6.  Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.

Authors:  U Broomé; R Olsson; L Lööf; G Bodemar; R Hultcrantz; A Danielsson; H Prytz; H Sandberg-Gertzén; S Wallerstedt; G Lindberg
Journal:  Gut       Date:  1996-04       Impact factor: 23.059

7.  Hepatic transplantation for primary and metastatic cancers of the liver.

Authors:  I Penn
Journal:  Surgery       Date:  1991-10       Impact factor: 3.982

8.  Changing trends in the management of extrahepatic cholangiocarcinoma.

Authors:  C M Guthrie; G Haddock; A C De Beaux; O J Garden; D C Carter
Journal:  Br J Surg       Date:  1993-11       Impact factor: 6.939

9.  Outcomes analysis for 280 patients with cholangiocarcinoma treated with liver transplantation over an 18-year period.

Authors:  Natasha S Becker; Joel A Rodriguez; Neal R Barshes; Christine A O'Mahony; John A Goss; Thomas A Aloia
Journal:  J Gastrointest Surg       Date:  2007-10-26       Impact factor: 3.452

Review 10.  Role of liver transplantation in the treatment of cholangiocarcinoma.

Authors:  Amit Singal; Theodore H Welling; Jorge A Marrero
Journal:  Expert Rev Anticancer Ther       Date:  2009-04       Impact factor: 4.512

View more
  11 in total

Review 1.  The Surgical Management of Klatskin Tumours: Has Anything Changed in the Last Decade?

Authors:  Neil Bhardwaj; Giuseppe Garcea; Ashley R Dennison; Guy J Maddern
Journal:  World J Surg       Date:  2015-11       Impact factor: 3.352

2.  Hilar cholangiocarcinoma: no longer hopeless.

Authors:  Charles B Rosen
Journal:  Dig Dis Sci       Date:  2014-05       Impact factor: 3.199

Review 3.  Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making.

Authors:  Irinel Popescu; Traian Dumitrascu
Journal:  Langenbecks Arch Surg       Date:  2014-05-20       Impact factor: 3.445

Review 4.  Liver transplantation for malignancies.

Authors:  Bijan Eghtesad; Federico Aucejo
Journal:  J Gastrointest Cancer       Date:  2014-09

Review 5.  Liver masses: a clinical, radiologic, and pathologic perspective.

Authors:  Sudhakar K Venkatesh; Vishal Chandan; Lewis R Roberts
Journal:  Clin Gastroenterol Hepatol       Date:  2013-09-18       Impact factor: 11.382

6.  Clinical analysis of cholangiocarcinoma patients receiving adjuvant radiotherapy.

Authors:  Danupon Nantajit; Pornwaree Trirussapanich; Sunanta Rojwatkarnjana; Kamonwan Soonklang; Poompis Pattaranutraporn; Kanyanee Laebua; Sasikarn Chamchod
Journal:  Mol Clin Oncol       Date:  2016-11-02

7.  The Clinical Management of Cholangiocarcinoma in the United States and Europe: A Comprehensive and Evidence-Based Comparison of Guidelines.

Authors:  Zhi Ven Fong; Sarah A Brownlee; Motaz Qadan; Kenneth K Tanabe
Journal:  Ann Surg Oncol       Date:  2021-03-01       Impact factor: 5.344

8.  Strict Selection Alone of Patients Undergoing Liver Transplantation for Hilar Cholangiocarcinoma Is Associated with Improved Survival.

Authors:  Hendrik T J Mantel; Andrie C Westerkamp; René Adam; William F Bennet; Daniel Seehofer; Utz Settmacher; Francisco Sánchez-Bueno; Joan Fabregat Prous; Emmanuel Boleslawski; Styrbjörn Friman; Robert J Porte
Journal:  PLoS One       Date:  2016-06-08       Impact factor: 3.240

9.  Comparison between liver transplantation and resection for hilar cholangiocarcinoma: A systematic review and meta-analysis.

Authors:  Dimitrios Moris; Ioannis D Kostakis; Nikolaos Machairas; Anastasia Prodromidou; Diamantis I Tsilimigras; Kadiyala V Ravindra; Debra L Sudan; Stuart J Knechtle; Andrew S Barbas
Journal:  PLoS One       Date:  2019-07-31       Impact factor: 3.240

Review 10.  Cholangiocarcinoma: Biology, Clinical Management, and Pharmacological Perspectives.

Authors:  Rocio I R Macias
Journal:  ISRN Hepatol       Date:  2014-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.